Table 1.
NSAIDs | Up- regulated targets |
Down- regulated targets |
Cancer types [References] |
---|---|---|---|
Sulindac sulfide | EGR-1 | Colon [80], Lung [13], brain [95] | |
ATF3 | Colon [20] | ||
NF-κB | Colon [46], Breast [96] | ||
NF-κB | Colon [50] | ||
β-catenin | Colon [53], lung and breast [97] | ||
EGFR | Colon [61] | ||
E-cadherin | Colon [63] | ||
PDE5 | Colon [67] | ||
NAG-1 | Colon [74], ovarian [78], Gastric [98], Prostate [99] | ||
Nesprin-2 | Colon [73] | ||
p21 | Breast [92], ovarian [78], Head/Neck [100], Pancreas [101] | ||
CHOP | Colon [28] | ||
Cyclin D1 | Breast [92], pancreas [101], colon [102] | ||
Tolfenamic acid | EGR-1 | Colon [15] | |
ATF3 | Colon [19] | ||
ATF4 | Colon [9] | ||
CHOP | Colon [9] | ||
Sp1 | Pancreas [36], Rhabdomyosarcoma [37], lung [38], esophageal [91]. Ovarian [103], colon [40] | ||
NF-κB | Colon [49] | ||
Smad2/3 | Lung [60] | ||
NAG-1 | Colon [15], Oral [76], thyroid [79] | ||
p21 | Breast [104] | ||
Cyclin D1 | Colon [9] |